Literature DB >> 27559718

Not only amblyopic but also dominant eye in subjects with strabismus show increased saccadic latency.

Maciej Perdziak, Dagmara K Witkowska, Wojciech Gryncewicz, Jan K Ober.   

Abstract

Amblyopia is a developmental disorder of vision usually associated with the presence of strabismus and/or anisometropia during early childhood. Subject literature has shown that both the amblyopic and fellow eyes (especially in strabismic subjects) may manifest a variety of perceptual and oculomotor deficits. Previous studies using simple saccadic responses (pro-saccades) showed an increased saccadic latency only for the amblyopic eye viewing conditions. So far, there have appeared no saccadic latency studies in strabismic amblyopia for more complex volitional saccades. In order to maximize the contribution of the central retina in the process of saccade initiation, we decided to use delayed saccadic responses in order to test the hypothesis about saccadic latency increase in both eyes in strabismic amblyopes. The results from our study have shown that saccadic latency is increased both in the dominant and amblyopic eyes. In addition, the amblyopic eye in the strabismic group showed greater increase in saccadic latency compared to an amblyopic eye in the anisometropic group from our previous study. The observed increase in saccadic reaction time for the dominant eye is novel and provides further evidence that the visual pathway associated with the dominant eye might be also impaired in strabismic amblyopia. Since an abnormal binocular input during visual system development may affect gaze stability in both eyes, we speculate that unsteady fixation accompanied with subtle perceptual deficits contribute to an increase in saccadic latency that is observed in the dominant eye. Moreover, it appears that the cortical processes related to saccade decisions are delayed both for amblyopic and fellow eyes in strabismic subjects.

Entities:  

Mesh:

Year:  2016        PMID: 27559718     DOI: 10.1167/16.10.12

Source DB:  PubMed          Journal:  J Vis        ISSN: 1534-7362            Impact factor:   2.240


  8 in total

Review 1.  Fellow Eye Deficits in Amblyopia.

Authors:  Eileen E Birch; Krista R Kelly; Deborah E Giaschi
Journal:  J Binocul Vis Ocul Motil       Date:  2019-06-04

2.  Both saccadic and manual responses in the amblyopic eye of strabismics are irreducibly delayed.

Authors:  Christina Gambacorta; Jian Ding; Suzanne P McKee; Dennis M Levi
Journal:  J Vis       Date:  2018-03-01       Impact factor: 2.240

Review 3.  Amblyopia: New molecular/pharmacological and environmental approaches.

Authors:  Michael P Stryker; Siegrid Löwel
Journal:  Vis Neurosci       Date:  2018-01       Impact factor: 3.241

Review 4.  Visuomotor Behaviour in Amblyopia: Deficits and Compensatory Adaptations.

Authors:  Ewa Niechwiej-Szwedo; Linda Colpa; Agnes M F Wong
Journal:  Neural Plast       Date:  2019-06-09       Impact factor: 3.599

Review 5.  Simplified updates on the pathophysiology and recent developments in the treatment of amblyopia: A review.

Authors:  Santhan K S Gopal; Jai Kelkar; Aditya Kelkar; Abhishek Pandit
Journal:  Indian J Ophthalmol       Date:  2019-09       Impact factor: 1.848

6.  Reach Kinematics During Binocular Viewing in 7- to 12-Year-Old Children With Strabismus.

Authors:  Krista R Kelly; Jeffrey Hunter; Dorsa Mir Norouzi; Reed M Jost; Ashley J White; Christina S Cheng-Patel; Cynthia L Beauchamp; Lori M Dao; Becky A Luu; David Stager; James Y Tung; Ewa Niechwiej-Szwedo
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-12-01       Impact factor: 4.799

7.  Delayed Correction for Extrapolation in Amblyopia.

Authors:  Xi Wang; Meng Liao; Yutong Song; Longqian Liu; Alexandre Reynaud
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-12-01       Impact factor: 4.799

8.  Orienting of covert attention by neutral and emotional gaze cues appears to be unaffected by mild to moderate amblyopia.

Authors:  Amy Chow; Yiwei Quan; Celine Chui; Roxane J Itier; Benjamin Thompson
Journal:  J Vis       Date:  2021-10-05       Impact factor: 2.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.